search
Back to results

The Effect of Doxycycline on Matrix Metalloproteinase Expression and Activity in the Abdominal Aneurysm

Primary Purpose

Aortic Aneurysm, Abdominal

Status
Completed
Phase
Phase 2
Locations
Netherlands
Study Type
Interventional
Intervention
doxycycline
Sponsored by
Leiden University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Aortic Aneurysm, Abdominal focused on measuring Collagenases, MMP, Cathepsins, Doxycycline, Aneurysm

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Elective open aneurysm repair

Exclusion Criteria:

  • Severe kidney and liver dysfunction

Sites / Locations

  • Leiden University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

Active Comparator

Active Comparator

Active Comparator

Arm Label

1

2

3

4

Arm Description

doxycycline 50 mg/day

doxycycline 100 mg

doxycycline 300 mg

Outcomes

Primary Outcome Measures

Collagenase mRNA and protein expression

Secondary Outcome Measures

Full Information

First Posted
October 2, 2007
Last Updated
October 2, 2007
Sponsor
Leiden University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00538967
Brief Title
The Effect of Doxycycline on Matrix Metalloproteinase Expression and Activity in the Abdominal Aneurysm
Official Title
The Effect of Doxycycline on Matrix Metalloproteinase Expression and Activity in the Abdominal Aneurysm
Study Type
Interventional

2. Study Status

Record Verification Date
October 2007
Overall Recruitment Status
Completed
Study Start Date
May 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Leiden University Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The matrix metalloproteinase-9 (MMP-9) is considered to play a central role in abdominal aortic aneurysm (AAA) initiation. Doxycycline has direct MMP-9 inhibiting properties in vitro, and it effectively suppresses AAA development in rodents. Observed inhibition of AAA progression, and contradictory findings in human studies evaluating the effect of doxycycline therapy on aortic wall MMP-9 suggest that the effects of doxycycline extend beyond MMP-9 inhibition, and that the effect may be dose dependent.
Detailed Description
In this clinical trial, we evaluated the effect of two weeks of low (50 mg/day), medium (100 mg/day) or high dose (300 mg/day) doxycycline versus no medication in patients undergoing elective AAA repair. The effect of doxycycline treatment on MMP and cysteine proteases, and their respective inhibitors was evaluated in an integrative approach.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Aneurysm, Abdominal
Keywords
Collagenases, MMP, Cathepsins, Doxycycline, Aneurysm

7. Study Design

Primary Purpose
Basic Science
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
No Intervention
Arm Title
2
Arm Type
Active Comparator
Arm Description
doxycycline 50 mg/day
Arm Title
3
Arm Type
Active Comparator
Arm Description
doxycycline 100 mg
Arm Title
4
Arm Type
Active Comparator
Arm Description
doxycycline 300 mg
Intervention Type
Drug
Intervention Name(s)
doxycycline
Intervention Description
2 weeks once daily
Primary Outcome Measure Information:
Title
Collagenase mRNA and protein expression
Time Frame
2 weeks

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Elective open aneurysm repair Exclusion Criteria: Severe kidney and liver dysfunction
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan HN Lindeman, MD, PhD
Organizational Affiliation
Leiden University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Leiden University Medical Center
City
Leiden
ZIP/Postal Code
2300RC
Country
Netherlands

12. IPD Sharing Statement

Learn more about this trial

The Effect of Doxycycline on Matrix Metalloproteinase Expression and Activity in the Abdominal Aneurysm

We'll reach out to this number within 24 hrs